The aim of this study was to test the biocompatibility between collagen-doxycycline matrices with various porosities and human endothelial cells. Collagen matrices were prepared by freeze-drying process. The crosslinking degree of collagen matrices was evaluated by FT-IR spectroscopy, the matrices morphology by SEM microscopy. The biocompatibility of collagen matrices with endothelial cells was monitored byfluorescence and transmission electron microscopy. We found that the three-dimensional structures of matrix with 1.2% collagen, 0.2% doxycycline crosslinked with 0.25% glutaraldehyde was optimal in terms of biodegradability, morphology and endothelial cells biocompatibility indicating the use of these scaffolds in tissueengineering.